Panacos files $113.75 million stock, warrant shelf

New York, March 27 - Panacos Pharmaceuticals, Inc. registered to sell up to $113.75 million of common stock and warrants in an S-3 shelf filing with the Securities and Exchange Commission.

Of the total, $100 million is new and $13.75 million is carried forward unsold from a previous registration.

Panacos, a Watertown, Mass., biotechnology company, will use proceeds for general corporate purposes, including its internal discovery and development programs and the development of new technologies, for general working capital and for possible future acquisitions.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.